Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.
Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T. Tanida S, et al. Among authors: watanabe k. Clin Gastroenterol Hepatol. 2015 May;13(5):940-8.e3. doi: 10.1016/j.cgh.2014.08.042. Epub 2014 Sep 19. Clin Gastroenterol Hepatol. 2015. PMID: 25245624 Free article. Clinical Trial.
Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K, Inoue T, Murano M, Narabayashi K, Nouda S, Ishida K, Abe Y, Nogami K, Hida N, Yamagami H, Watanabe K, Umegaki E, Nakamura S, Arakawa T, Higuchi K. Kawakami K, et al. Among authors: watanabe k. World J Gastroenterol. 2015 Feb 14;21(6):1880-6. doi: 10.3748/wjg.v21.i6.1880. World J Gastroenterol. 2015. PMID: 25684955 Free PMC article.
Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y, Watanabe K, Ito H, Nishishita M, Sawada K, Okuyama Y, Okazaki K, Fujii H, Nakase H, Masuda T, Fukunaga K, Andoh A, Nakamura S. Yokoyama Y, et al. Among authors: watanabe k. Cytotherapy. 2015 May;17(5):680-8. doi: 10.1016/j.jcyt.2015.02.007. Epub 2015 Mar 21. Cytotherapy. 2015. PMID: 25804800 Clinical Trial.
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.
Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T. Yoshimura N, et al. Among authors: watanabe k. BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3. BMC Gastroenterol. 2015. PMID: 26585569 Free PMC article. Clinical Trial.
Serum interleukin-6 level is associated with response to infliximab in ulcerative colitis.
Nishida Y, Hosomi S, Watanabe K, Watanabe K, Yukawa T, Otani K, Nagami Y, Tanaka F, Taira K, Kamata N, Yamagami H, Tanigawa T, Watanabe T, Fujiwara Y. Nishida Y, et al. Among authors: watanabe t, watanabe k. Scand J Gastroenterol. 2018 May;53(5):579-585. doi: 10.1080/00365521.2017.1403647. Epub 2017 Nov 24. Scand J Gastroenterol. 2018. PMID: 29171305
Evidence-based clinical practice guidelines for inflammatory bowel disease.
Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T. Matsuoka K, et al. Among authors: watanabe t, watanabe k, watanabe m. J Gastroenterol. 2018 Mar;53(3):305-353. doi: 10.1007/s00535-018-1439-1. Epub 2018 Feb 10. J Gastroenterol. 2018. PMID: 29429045 Free PMC article.
[Cutting edge of medical therapy to inflammatory bowel disease].
Nakamura S, Hida N, Watanabe K. Nakamura S, et al. Among authors: watanabe k. Nihon Shokakibyo Gakkai Zasshi. 2018;115(3):233-243. doi: 10.11405/nisshoshi.115.233. Nihon Shokakibyo Gakkai Zasshi. 2018. PMID: 29526975 Japanese. No abstract available.
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.
Kobayashi T, Hisamatsu T, Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto T, Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa T, Sasaki M, Yokoyama K, Yoshimura N, Watanabe K, Katafuchi M, Watanabe M, Hibi T. Kobayashi T, et al. Among authors: watanabe k, watanabe m. Intest Res. 2018 Apr;16(2):168-177. doi: 10.5217/ir.2018.16.2.168. Epub 2018 Apr 30. Intest Res. 2018. PMID: 29743830 Free PMC article. Review.
16,131 results
You have reached the last available page of results. Please see the User Guide for more information.